Patent · US Active

Estrogen receptor ligands

US8653072B2 · kind B2 · utility

2Cited by

7References

19Claims

0Family size

Assignee

Karo Bio AB · SE

Inventors

Patrik Rhönnstad · Malmö, SE
Elisabet Kallin · Tullinge, SE
Theresa Apelqvist · Munkedal, SE
Mattias Wennerstål · Åtvidaberg, SE
Aiping Cheng · Huddinge, SE

Key dates

Filing date	Jan 11, 2013
Grant date	Feb 18, 2014
Priority date	—
Expiry date	Jan 11, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a compound of formula (I) or a pharmaceutically acceptable ester, amide, carbamate, solvate or salt thereof, including a salt of such an ester, amide or carbamate, and a solvate of such an ester, amide, carbamate or salt. The invention also provides also provides the use of such compounds in the treatment or prophylaxis of a condition associated with a disease or disorder associated with estrogen receptor activity, wherein R1, R2, R3, R5 and R6 are as defined in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.